Quantcast
Home / Opinion Digests / $22.35 million defamation award vacated (access required)

$22.35 million defamation award vacated (access required)

Where a jury awarded $22.35 million to a healthcare investor because he was defamed by a biotechnology company, but the jury did not receive evidence sufficient to support the award, the award was vacated and the case was remanded for a new trial on damages. Background In 2019, a jury found Puma Biotechnology Inc. had defamed Fredric ...